Juniper Pharma (JNP) Tops Q4 EPS by 43c

Juniper Pharma (NASDAQ: JNP) reported Q4 EPS of $0.88, $0.43 better than the analyst estimate of $0.45. Revenue for the quarter came in at $20.9 million versus the consensus estimate of $15.33 million.

For earnings history and earnings-related data on Juniper Pharma (JNP) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c